SCHEMBL25812952

SCHEMBL25812952

CC(=O)OCC(C)(F)S(=O)(=O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
LMNA P02545 1/20 0.36
HSD17B10 Q99714 1/20 0.36
GAA P10253 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
TDP1 Q9NUW8 1/20 0.31
HTT P42858 1/20 0.30
PGR P06401 1/20 0.30
CHRM2 P08172 1/20 0.30
CHRM4 P08173 1/20 0.30
HTR1A P08908 1/20 0.30
CHRM5 P08912 1/20 0.30
CHRM1 P11229 1/20 0.30
CHRNB2 P17787 1/20 0.30
CHRM3 P20309 1/20 0.30
TBXA2R P21731 1/20 0.30
CHRNB4 P30926 1/20 0.30
CHRNA3 P32297 1/20 0.30
CHRNA7 P36544 1/20 0.30
CHRNA4 P43681 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL687031 0.81 ALDH1A1 (0.37) ALDH1A1LMNAHSD17B10GAAL3MBTL1
SCHEMBL16213952 0.80 ALDH1A1 (0.33) ALDH1A1LMNAHSD17B10L3MBTL1
SCHEMBL686743 0.79 ALDH1A1 (0.36) ALDH1A1LMNAHSD17B10L3MBTL1TDP1
SCHEMBL19320562 0.78 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10GAAPGR
SCHEMBL687033 0.78 ALDH1A1 (0.34) ALDH1A1LMNAHSD17B10L3MBTL1
SCHEMBL685290 0.75
SCHEMBL686167 0.75
SCHEMBL12895538 0.72 ALDH1A1 (0.37) ALDH1A1LMNAHSD17B10GAATDP1
SCHEMBL6876173 0.72 ALDH1A1 (0.46) ALDH1A1LMNAHSD17B10GAATDP1
SCHEMBL12445294 0.72 ALDH1A1 (0.46) ALDH1A1LMNAHSD17B10GAATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11709425-B2 Resist composition and method of forming resist pattern TOKYO OHKA KOGYO CO., LTD. (JP) 2023-07-25 US disclosed
US-11703756-B2 Resist composition and method of forming resist pattern TOKYO OHKA KOGYO CO., LTD. (JP) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11709425-B2 Resist composition and method of forming resist pattern RER1, RRS1, RXFP4 ALDH1A1 3475/4885LMNA 4574/4885HSD17B10 661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.